Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2023-07-13 | 2023-10-15 | 198473 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2020-09-30 | 2020-10-13 | 125332 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-06-20 | 2024-08-02 | 231010 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-09-12 | 2024-09-27 | 237360 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2024-10-18 | 2024-12-20 | 240613 |
| APO-BENZYDAMINE ORAL RINSE | 0.15% | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19087 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-09-04 | 2018-08-23 | 20860 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2017-03-10 | 2017-04-03 | 67 |
| APO-BICALUTAMIDE | 50MG | TABLET | Resolved | 2020-09-09 | 2020-09-28 | 123892 |
| APO-BILASTINE TABLETS | 20MG | TABLET | Resolved | 2025-03-20 | 2025-04-11 | 253067 |
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-01-03 | 2018-09-09 | 34835 |
| APO-BISACODYL SUP 10MG | 10MG | SUPPOSITORY | Actual shortage | 2017-08-13 | 2017-10-05 | 18985 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2017-07-26 | 2017-12-14 | 17208 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2020-09-09 | 2020-10-05 | 123914 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2018-08-21 | 2019-01-02 | 58580 |
| APO-BISOPROLOL | 5MG | TABLET | Resolved | 2024-04-12 | 2024-07-19 | 225023 |
| APO-BISOPROLOL | 10MG | TABLET | Resolved | 2017-10-17 | 2017-12-04 | 26154 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2018-01-17 | 2018-04-09 | 36268 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2018-05-22 | 2018-07-17 | 50041 |
| APO-BRIMONIDINE-TIMOP | 0.5% 0.2% | SOLUTION | Resolved | 2024-05-03 | 2024-05-10 | 227028 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |